AFT Pharmaceuticals Limited (NZE:AFT)

AFT Pharmaceuticals Ratios and Metrics

Market cap in millions NZD. Fiscal year is April - March.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	May 14, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Market Capitalization	280	328	363	378	518	353
Market Cap Growth	-6.11%	-9.54%	-4.00%	-26.99%	46.56%	81.50%
Enterprise Value	303	363	395	414	556	397
Last Close Price	2.67	3.11	3.43	3.58	4.91	3.60
PE Ratio	26.25	21.03	34.06	19.04	68.17	30.20
Forward PE	18.45	19.41	19.12	18.43	30.80	27.90
PS Ratio	1.41	1.68	2.32	2.90	4.58	3.35
PB Ratio	3.35	3.74	4.95	6.07	14.15	20.47
P/TBV Ratio	10.26	4.60	6.35	8.16	24.65	-
P/FCF Ratio	10.96	11.42	31.74	27.34	787.96	23.89
P/OCF Ratio	10.88	11.37	31.20	26.71	690.25	23.74
PEG Ratio	0.90	0.54	1.61	0.38	-	-
EV/Sales Ratio	1.52	1.86	2.52	3.18	4.92	3.76
EV/EBITDA Ratio	14.64	14.74	19.89	20.04	50.70	33.78
EV/EBIT Ratio	15.78	14.98	20.10	20.31	51.93	34.55
EV/FCF Ratio	11.84	12.63	34.58	29.96	846.29	26.88
Debt / Equity Ratio	0.40	0.37	0.52	0.65	1.15	2.74
Debt / EBITDA Ratio	1.63	1.27	1.85	1.90	3.61	3.79
Debt / FCF Ratio	1.32	1.12	3.33	2.93	64.26	3.19
Asset Turnover	1.29	1.25	1.14	1.12	1.18	1.40
Inventory Turnover	2.15	2.34	2.21	2.04	2.28	2.39
Quick Ratio	1.21	1.15	1.12	1.30	1.01	1.15
Current Ratio	2.72	2.30	2.38	2.67	2.12	2.20
Return on Equity (ROE)	14.40%	19.38%	15.72%	40.14%	28.91%	113.59%
Return on Assets (ROA)	7.82%	9.67%	8.93%	10.96%	6.97%	9.54%
Return on Capital (ROIC)	10.33%	13.10%	11.48%	14.03%	9.34%	12.92%
Return on Capital Employed (ROCE)	16.50%	20.30%	18.20%	20.70%	14.70%	18.60%
Earnings Yield	4.15%	4.75%	2.94%	5.25%	1.50%	3.59%
FCF Yield	9.13%	8.76%	3.15%	3.66%	0.13%	4.19%
Dividend Yield	0.61%	0.51%	0.32%	-	-	-
Payout Ratio	14.46%	7.39%	-	-	2.42%	4.46%
Buyback Yield / Dilution	-56.43%	-0.02%	-0.16%	-1.34%	-6.15%	-0.00%
Total Shareholder Return	-55.82%	0.50%	0.16%	-1.34%	-6.15%	-0.00%

Updated Nov 21, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.